Author

Annemarie F. Charvat

University of California, San FranciscoORCID 0009-0002-1164-4816Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Organism:human· 1

Frequent Co-Authors

Abby Oehler· 1 shared Adam R. RensloiD· 1 shared Alexander I. P. TayloriD· 1 shared Alicia RichardsiD· 1 shared Amy DialloiD· 1 shared Anthony YungiD· 1 shared Brian K. ShoichetiD· 1 shared Carlo CondelloiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Abby Oehler

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistryNature ChemistryPeer-reviewedAug 14, 2025

Methods for high throughput discovery of fluoroprobes that recognize tau fibril polymorphs

Emma C. Carroll, Hyunjun Yang, Wyatt C. Powell…·Jason E. Gestwicki

The paper develops a high-throughput method to identify fluoroprobes that distinguish between tau fibril polymorphs using paDSF and chemical screening.

14 citationstop 4%

proteomicsexperimental assay

𝕏 PostBluesky

BiochemistryScience AdvancesPeer-reviewedApr 23, 2025

Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus-MPro inhibitors with potent in vivo efficacy

Tyler C. Detomasi, Gilles Degotte, Sijie Huang…·Charles S. Craik

This paper describes the discovery of new coronavirus MPro inhibitors with improved pharmacokinetics, broad-spectrum antiviral activity, and superior in vivo efficacy compared to existing drugs.

16 citationstop 1%

humanproteomics

𝕏 PostBluesky